化学
体内
脚手架
效力
唑
药物发现
结构-活动关系
体外
药理学
立体化学
生物化学
生物医学工程
生物技术
皮肤病科
生物
医学
抗真菌
作者
Masayuki Kotoku,Takaki Maeba,Shingo Fujioka,Masahiro Yokota,Noriyoshi Seki,Keisuke Ito,Yoshihiro Suwa,Taku Ikenogami,Kazuyuki Hirata,Yasunori Hase,Yoshiaki Katsuda,Naoki Miyagawa,Kojo Arita,Kota Asahina,Masato Noguchi,Akihiro Nomura,Satoki Doi,Tsuyoshi Adachi,Paul D. Crowe,Haiyan Tao
标识
DOI:10.1021/acs.jmedchem.8b01567
摘要
Starting from a previously reported RORγ inhibitor (1), successive efforts to improve in vivo potency were continued. Introduction of metabolically beneficial motifs in conjunction with scaffold hopping was examined, resulting in discovery of the second generation RORγ inhibitor composed of a 4-(isoxazol-3-yl)butanoic acid scaffold (24). Compound 24 achieved a 10-fold improvement in in vivo potency in a mouse CD3 challenge model along with significant anti-inflammatory effects in a mouse dermatitis model.
科研通智能强力驱动
Strongly Powered by AbleSci AI